Literature DB >> 14751243

Transient posttranslational up-regulation of telomerase activity during megakaryocytic differentiation of K562 cells.

M Nakatake1, N Sasaki, K Murakami-Murofushi, O Yamada.   

Abstract

Telomerase is active in immature somatic cells, but not in differentiated cells. However, the mechanism by which telomerase is regulated in relation to cell differentiation is not well understood. In this study, the human erythroid leukemia cell line K562 was induced to differentiate into megakaryocytes by TPA and into erythroid by STI571. The human acute myeloblastic leukemia cell line HL60 was also induced to differentiate into monocytes by TPA. Telomerase activity, the expression of human telomerase reverse transcriptase, hTERT, and the cell cycle were examined. TPA induced a transient increase in telomerase activity during the megakaryocytic differentiation while the message of hTERT decreased gradually throughout the same period. This suggests the existence of a regulatory mechanism other than transcription of hTERT. Cell cycle analysis revealed that cells in G(2)/M phase increased in number in accordance with the changes in telomerase activity. Pretreatment with PKC inhibitors inhibited the megakaryocytic differentiation, transient increase in telomerase activity, and G(2)/M arrest. These results suggest that PKC acts as a transient post-translational activator of telomerase during megakaryocytic differentiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14751243     DOI: 10.1016/j.bbrc.2003.12.199

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Combined analysis of cell growth and apoptosis-regulating proteins in HPVs associated anogenital tumors.

Authors:  Tsuyoshi Mitsuishi; Yukie Iwabu; Kenzo Tokunaga; Tetsutaro Sata; Takehiko Kaneko; Kuniaki Ohara; Ikuroh Ohsawa; Fumino Oda; Yuko Yamada; Seiji Kawana; Kohji Ozaki; Mayuka Nakatake; Osamu Yamada
Journal:  BMC Cancer       Date:  2010-03-27       Impact factor: 4.430

Review 2.  The role of the JAK-STAT pathway and related signal cascades in telomerase activation during the development of hematologic malignancies.

Authors:  Osamu Yamada; Kiyotaka Kawauchi
Journal:  JAKSTAT       Date:  2013-06-12

3.  Myelosuppression in Patients Treated with the Telomerase Inhibitor Imetelstat Is Not Mediated through Activation of Toll-Like Receptors.

Authors:  Gabriela M Baerlocher; Joshua Rusbuldt; Jacqueline Bussolari; Fei Huang
Journal:  Int J Mol Sci       Date:  2020-09-08       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.